Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriersT.C. van Sprundel, Rob A.�E.�M. Tollenaar, Matti A. Rookus et al.|British Journal of Cancer|2005Cited by 291